Purpose <p>The Celeris system (Diagnosys LLC) offers a streamlined alternative to the gold-standard Espion system for high-throughput electroretinography (ERG) and visual evoked potentials (VEP) in preclinical studies. This study evaluated its inter-session repeatability of ERG and VEP measurements in healthy rodent&#xa0;retinae.</p> Methods <p>Twenty-five wild type Brown Norway rats underwent ERG and VEP testing across two sessions. Dark-adapted ERG a- and b-waves (flash stimulus of 10&#xa0;cd&#xa0;s/m<sup>2</sup>), and the photopic negative response (PhNR) (flash stimulus of 3&#xa0;cd&#xa0;s/m<sup>2</sup>) were recorded. VEPs (flash stimulus of 3&#xa0;cd&#xa0;s/m<sup>2</sup>) were recorded from implanted screw electrodes in the skull. Pearson’s correlation coefficient (ρ), Bland–Altman with 95% limits of agreement (LOA) and a novel cumulative distribution plot were used to assess inter-session agreement.</p> Results <p>Intersession dark-adapted a-wave showed a correlation of ρ = 0.73, (P &lt; 0.0001), LOA: –106.4 to 113.9&#xa0;µV, and 90% of measurements fell within − 24.8 to 58.0% variation (90% range). Intersession dark-adapted b-wave amplitudes showed ρ = 0.65, (P &lt; 0.001), LOA: − 402.5 to 437.4&#xa0;µV, and 90% range: − 33.7 to 72.6%. Inter-session PhNR-B (base-to-trough) and PhNR-P (peak-to-trough) amplitudes showed ρ = 0.66 and 0.72 respectively; LOA: − 26.7 to 31.1&#xa0;µV and − 98.9 to 100.1&#xa0;µV respectively; 90% ranges: − 58.2 to 59.3%, and − 45.6 to 60.9%, respectively. Inter-session VEP P2 amplitude showed ρ = 0.67, (P &lt; 0.001), LOA: 78.5–72.8&#xa0;µV, and 90% range: − 52.2 to 67.9%. Inter-session VEP implicit time showed ρ = 0.48, (P &lt; 0.05), LOA: − 39.4 to 38.3&#xa0;ms, and 90% range: − 39.2% to 16.7%.</p> Conclusion <p>The study reported the inter-session repeatability of the ERG and VEP tests using the Celeris system. These data facilitate the study design and sample size calculation for future preclinical studies using the Celeris, and serve as a reference for future comparison with other systems, protocols and species.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Inter-session repeatability of electroretinography and visual evoked potentials of the Celeris system

  • Xiuying Tang,
  • Carla J. Abbott,
  • Penelope J. Allen,
  • Chi D. Luu

摘要

Purpose

The Celeris system (Diagnosys LLC) offers a streamlined alternative to the gold-standard Espion system for high-throughput electroretinography (ERG) and visual evoked potentials (VEP) in preclinical studies. This study evaluated its inter-session repeatability of ERG and VEP measurements in healthy rodent retinae.

Methods

Twenty-five wild type Brown Norway rats underwent ERG and VEP testing across two sessions. Dark-adapted ERG a- and b-waves (flash stimulus of 10 cd s/m2), and the photopic negative response (PhNR) (flash stimulus of 3 cd s/m2) were recorded. VEPs (flash stimulus of 3 cd s/m2) were recorded from implanted screw electrodes in the skull. Pearson’s correlation coefficient (ρ), Bland–Altman with 95% limits of agreement (LOA) and a novel cumulative distribution plot were used to assess inter-session agreement.

Results

Intersession dark-adapted a-wave showed a correlation of ρ = 0.73, (P < 0.0001), LOA: –106.4 to 113.9 µV, and 90% of measurements fell within − 24.8 to 58.0% variation (90% range). Intersession dark-adapted b-wave amplitudes showed ρ = 0.65, (P < 0.001), LOA: − 402.5 to 437.4 µV, and 90% range: − 33.7 to 72.6%. Inter-session PhNR-B (base-to-trough) and PhNR-P (peak-to-trough) amplitudes showed ρ = 0.66 and 0.72 respectively; LOA: − 26.7 to 31.1 µV and − 98.9 to 100.1 µV respectively; 90% ranges: − 58.2 to 59.3%, and − 45.6 to 60.9%, respectively. Inter-session VEP P2 amplitude showed ρ = 0.67, (P < 0.001), LOA: 78.5–72.8 µV, and 90% range: − 52.2 to 67.9%. Inter-session VEP implicit time showed ρ = 0.48, (P < 0.05), LOA: − 39.4 to 38.3 ms, and 90% range: − 39.2% to 16.7%.

Conclusion

The study reported the inter-session repeatability of the ERG and VEP tests using the Celeris system. These data facilitate the study design and sample size calculation for future preclinical studies using the Celeris, and serve as a reference for future comparison with other systems, protocols and species.